These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3932846)

  • 1. Metabolic activation of hepatocarcinogens in chronic hepatitis B.
    De Flora S; Romano M; Basso C; Serra D; Astengo M; Picciotto A
    Mutat Res; 1985 Nov; 144(3):213-9. PubMed ID: 3932846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
    Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
    Israel-Kalinsky H; Malca-Mor L; Stark AA
    Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98.
    Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K
    J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
    Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
    Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
    Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
    Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
    Harries GC; Boobis AR; Collier N; Davies DS
    Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus.
    De Flora S; Hietanen E; Bartsch H; Camoirano A; Izzotti A; Bagnasco M; Millman I
    Carcinogenesis; 1989 Jun; 10(6):1099-106. PubMed ID: 2720903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver.
    Matsuoka H; Aji T; Ishii A; Arimoto S; Wataya Y; Hayatsu H
    Mutat Res; 1989 Nov; 227(3):153-7. PubMed ID: 2509904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-dependent effects of dietary lindane and/or zineb on the activation of aflatoxin B1 into mutagenic derivatives.
    Decloitre F; Hamon G
    Mutat Res; 1980 Nov; 79(3):185-92. PubMed ID: 6163982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay.
    Dashwood RH; Breinholt V; Bailey GS
    Carcinogenesis; 1991 May; 12(5):939-42. PubMed ID: 1903094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by specific antibodies of the mutagenicity of aflatoxin B1 in bacteria.
    Sizaret P; Malaveille C; Brun G; Aguelon AM; Toussaint G
    Oncodev Biol Med; 1982; 3(2-3):125-34. PubMed ID: 6812028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat modifies the in vivo mutagenicity of some food-borne carcinogens.
    Brennan-Craddock WE; Coutts TM; Rowland IR; Alldrick AJ
    Mutat Res; 1990 May; 230(1):49-54. PubMed ID: 2111458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system.
    Coulombe RA; Shelton DW; Sinnhuber RO; Nixon JE
    Carcinogenesis; 1982; 3(11):1261-4. PubMed ID: 6758974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.